Revol-Cavalier J, Quaranta A, Newman J, Brash A, Hamberg M, Wheelock C
Chem Rev. 2024; 125(1):1-90.
PMID: 39680864
PMC: 11719350.
DOI: 10.1021/acs.chemrev.3c00520.
Moller M, Vitturi D
Redox Biochem Chem. 2024; 8.
PMID: 38957295
PMC: 11218869.
DOI: 10.1016/j.rbc.2024.100026.
Chang F, Gunderstofte C, Colussi N, Pitts M, Salvatore S, Thielke A
Redox Biol. 2024; 74:103202.
PMID: 38865901
PMC: 11215336.
DOI: 10.1016/j.redox.2024.103202.
Yan F, Liu C, Song D, Zeng Y, Zhan Y, Zhuang X
Cell Biol Toxicol. 2024; 40(1):25.
PMID: 38691184
PMC: 11063108.
DOI: 10.1007/s10565-024-09861-w.
Lee J, Lee A, Choi E, Choi I, Kim S
Inflammopharmacology. 2023; 32(1):561-573.
PMID: 37921960
DOI: 10.1007/s10787-023-01340-8.
Digestive interaction between dietary nitrite and dairy products generates novel nitrated linolenic acid products.
Salvatore S, Gomez-Cortes P, Rowart P, Woodcock S, de la Fuente M, Chang F
Food Chem. 2023; 437(Pt 1):137767.
PMID: 37879157
PMC: 10844836.
DOI: 10.1016/j.foodchem.2023.137767.
Analysis of Phosphatidylinositol Modifications by Reactive Nitrogen Species Using LC-MS: Coming to Grips with Their Nitroxidative Susceptibility.
Bonciarelli S, Neves B, Domingues P, Melo T, Goracci L, Domingues M
J Am Soc Mass Spectrom. 2023; 34(7):1372-1382.
PMID: 37343944
PMC: 10326911.
DOI: 10.1021/jasms.3c00057.
The effects of conjugated linoleic acid supplementation on inflammatory cytokines and adipokines in adults: A GRADE-assessed systematic review and dose-response meta-analysis.
Rastgoo S, Shimi G, Shiraseb F, Karbasi A, Ashtary-Larky D, Yousefi M
Front Immunol. 2023; 14:1092077.
PMID: 36911696
PMC: 9992184.
DOI: 10.3389/fimmu.2023.1092077.
Protective Effect of NO-OA on Oxidative Stress, Gliosis, and Pro-Angiogenic Response in Müller Glial Cells.
Vaglienti M, Subirada P, Joray M, Bonacci G, Sanchez M
Cells. 2023; 12(3).
PMID: 36766836
PMC: 9914399.
DOI: 10.3390/cells12030494.
Nitro-oleic acid regulates T cell activation through post-translational modification of calcineurin.
Bago A, Cayuela M, Gil A, Calvo E, Vazquez J, Queiro A
Proc Natl Acad Sci U S A. 2023; 120(4):e2208924120.
PMID: 36652486
PMC: 9942794.
DOI: 10.1073/pnas.2208924120.
Post-Translational Modifications of STING: A Potential Therapeutic Target.
Kang J, Wu J, Liu Q, Wu X, Zhao Y, Ren J
Front Immunol. 2022; 13:888147.
PMID: 35603197
PMC: 9120648.
DOI: 10.3389/fimmu.2022.888147.
Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis.
Rom O, Liu Y, Finney A, Ghrayeb A, Zhao Y, Shukha Y
Redox Biol. 2022; 52:102313.
PMID: 35447412
PMC: 9044008.
DOI: 10.1016/j.redox.2022.102313.
Lipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion.
Yu G, Ramasamy T, Fazzari M, Chen X, Freeman B, Pacella J
Nanotheranostics. 2022; 6(2):215-229.
PMID: 34976596
PMC: 8671954.
DOI: 10.7150/ntno.62351.
Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis.
Hansen A, Rahbek L, Sorensen A, Hundahl M, Lomholt S, Holm C
BMC Immunol. 2021; 22(1):77.
PMID: 34920714
PMC: 8684285.
DOI: 10.1186/s12865-021-00471-3.
Nitro-fatty acids: electrophilic signaling molecules in plant physiology.
Di Fino L, Arruebarrena Di Palma A, Perk E, Garcia-Mata C, Schopfer F, Laxalt A
Planta. 2021; 254(6):120.
PMID: 34773515
PMC: 10704571.
DOI: 10.1007/s00425-021-03777-z.
Chemoproteomic profiling reveals cellular targets of nitro-fatty acids.
Fang M, Huang K, Tu W, Chen Y, Pan P, Hsiao W
Redox Biol. 2021; 46:102126.
PMID: 34509914
PMC: 8441202.
DOI: 10.1016/j.redox.2021.102126.
Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
Liu Y, Zhao Y, Shukha Y, Lu H, Wang L, Liu Z
Cell Rep. 2021; 36(4):109420.
PMID: 34320345
PMC: 8363062.
DOI: 10.1016/j.celrep.2021.109420.
Endogenous generation of nitro-fatty acid hybrids having dual nitrate ester (RONO) and nitroalkene (RNO) substituents.
Fazzari M, Woodcock S, Rowart P, Ricart K, Lancaster Jr J, Patel R
Redox Biol. 2021; 41:101913.
PMID: 33819836
PMC: 8049994.
DOI: 10.1016/j.redox.2021.101913.
Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.
Nielsen J, Rom O, Surakka I, Graham S, Zhou W, Roychowdhury T
Nat Commun. 2020; 11(1):6417.
PMID: 33339817
PMC: 7749177.
DOI: 10.1038/s41467-020-20086-3.
Mass spectrometry-based study defines the human urine nitrolipidome.
Salvatore S, Rowart P, Schopfer F
Free Radic Biol Med. 2020; 162:327-337.
PMID: 33131723
PMC: 10895545.
DOI: 10.1016/j.freeradbiomed.2020.10.305.